Although the relationships between serum miRNAs and HBV-related diseases, such as cirrhosis and HCC have been widely investigated previously [12], the information about the characteristics of serum IFN signaling-related miRNAs in OBI patients is limited. Here, IFNA1 is linked to hepatocellular carcinoma.